9th Annual Biomarkers Congress
Production & Manufacturing of Vaccines


Cambridge, Massachusetts
http://www.healthtech.com/imt/vpd/
Production & Manufacturing of Vaccines 

Schedule of Presentations:

Tuesday, August 17, 2010
07:20:00 Registration and Morning Coffee
08:15:00 REGULATORY UPDATE / CELL LINES AND PRODUCTION PLATFORMS
08:20:00 Chairperson’s Opening Remarks
08:30:00 Opening Keynote Presentation | Regulatory Authority Perspective on Handling Vaccine Production, Manufacturing and Process Change Norman Baylor
09:15:00 Production of Influenza Vaccines Using a Fungal Production Platform Debbie Higgins
09:45:00 Case Study on Designer Duck Cell Lines and Vectored Vaccines AGE1-CR: A Production Platform for Vectored Vaccines Volker Sandig,
10:15:00 Networking Coffee Break with Exhibit and Poster Viewing
10:55:00 PROCESS DEVELOPMENT, OPTIMIZATION, AND VALIDATION
11:00:00 Optimization of a Process for an Attenuated Influenza Vaccine Produced on Vero Cells Thomas Muster
11:30:00 Designing and Validating a Manufacturing Process Trevor Deeks
12:00:00 Purification Platform for Influenza Viruses and Vaccines Matjaz Peterka
12:30:00 Luncheon Presentation Technological Advances for Vaccine Processing Ian Sellick
13:50:00 FOCUS ON DOWNSTREAM PROCESSING & MAINTAINING STERILTY
13:55:00 Chairperson’s Remarks
14:00:00 Challenges and Solutions to Downstream Bioprocessing Operations for the Manufacture of Vaccine Candidates Timothy Lee
14:30:00 Purification Development for a Live Attenuated Influenza Virus from MDCK Cell Culture Simon Hsu
15:00:00 Manufacturing a Sterile, Autologous Colon Tumor Derived Vaccine for a Patient Specific Immunotherapeutic Treatment Michael G. Hanna
15:30:00 Networking Refreshment Break with Exhibit and Poster Viewing
16:10:00 STABILITY AND FORMULATION, AND COLLABORATION FOR MANUFACTURING OUTSIDE THE US AND EU
16:15:00 Spray Drying in Vaccine Manufacturing for Improved Stability Tom Jin
16:45:00 Development of a Recombinant Vaccine to Treat Vaginal Candidiasis – From the Bench to Clinical Testing Rinaldo Zurbriggen
17:15:00 Benefits of Manufacturing Vaccines Outside the US and Europe: Focus on Korea Bill Enright
17:45:00 Reception with Exhibit and Poster Viewing
18:45:00 End of Day
Wednesday, August 18, 2010
07:30:00 Morning Coffee (Breakfast Sponsored Presentation Opportunity Available)
08:20:00 SCALE-UP AND RAPID RESPONSE TO PANDEMICS
08:25:00 Chairperson’s Remarks
08:30:00 Scale-Up of an Intensified Process for rAd35 Adenovirus Production using the PER.C6® Cell Substrate Herman van Herk
09:00:00 Technical Challenges and Solutions for Development, Manufacturing Scale-Up and Management of Seasonal Strain Changes for Recombinant Influenza Vaccine Albert Price
09:30:00 Staying Live: Scale-Up of an Attenuated Respiratory Syncytial Virus (RSV) Vaccine Mark W. Thompson
10:00:00 Networking Coffee Break with Exhibit and Poster Viewing
10:40:00 WORKING WITH THE REGULATORY AUTHORITIES / PRODUCT QUALITY AND ANALYTICAL CHARACTERIZATION
10:45:00 After the License Approval - What Can Analytics Do? Robert D. Sitrin
11:15:00 Industry Perspective on Handling the Complex and Sometimes Undefined Regulatory Requirements Michael Dekleva
11:45:00 Meeting Regulatory Challenges through Better Characterization of Vaccine Production Substrates Jonathan Liu
12:15:00 End of “Production & Manufacturing of Vaccines” meeting
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.